Free Trial

Fred Alger Management LLC Raises Holdings in Cadre Holdings, Inc. (NYSE:CDRE)

Cadre logo with Industrial Products background

Fred Alger Management LLC lifted its position in Cadre Holdings, Inc. (NYSE:CDRE - Free Report) by 19.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 393,638 shares of the company's stock after purchasing an additional 64,543 shares during the quarter. Fred Alger Management LLC owned about 0.97% of Cadre worth $13,210,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Harel Insurance Investments & Financial Services Ltd. raised its position in shares of Cadre by 454.3% during the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,624 shares of the company's stock valued at $55,000 after buying an additional 1,331 shares during the period. New York State Teachers Retirement System boosted its position in shares of Cadre by 1,640.0% during the first quarter. New York State Teachers Retirement System now owns 1,740 shares of the company's stock worth $63,000 after buying an additional 1,640 shares during the period. Canada Pension Plan Investment Board purchased a new stake in shares of Cadre in the 2nd quarter valued at $141,000. Oppenheimer Asset Management Inc. acquired a new position in Cadre during the 2nd quarter worth about $216,000. Finally, Susquehanna Fundamental Investments LLC purchased a new position in Cadre during the 1st quarter valued at about $225,000. 43.95% of the stock is owned by hedge funds and other institutional investors.

Cadre Stock Up 1.3 %

Shares of CDRE traded up $0.48 during mid-day trading on Thursday, hitting $37.88. 215,535 shares of the company's stock were exchanged, compared to its average volume of 239,997. The stock's 50-day moving average is $35.60 and its 200-day moving average is $34.41. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.14 and a current ratio of 3.17. Cadre Holdings, Inc. has a fifty-two week low of $26.08 and a fifty-two week high of $39.81. The company has a market cap of $1.54 billion, a price-to-earnings ratio of 37.03, a P/E/G ratio of 2.22 and a beta of 1.28.

Cadre (NYSE:CDRE - Get Free Report) last released its earnings results on Friday, August 9th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.04. Cadre had a net margin of 7.55% and a return on equity of 17.45%. The company had revenue of $144.31 million for the quarter, compared to analyst estimates of $142.06 million. During the same period in the prior year, the business earned $0.29 EPS. The firm's quarterly revenue was up 19.2% on a year-over-year basis. On average, sell-side analysts anticipate that Cadre Holdings, Inc. will post 1.04 earnings per share for the current fiscal year.

Cadre Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Stockholders of record on Friday, August 2nd were paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.92%. The ex-dividend date was Friday, August 2nd. Cadre's payout ratio is presently 34.65%.

Cadre Profile

(Free Report)

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.

Featured Articles

Institutional Ownership by Quarter for Cadre (NYSE:CDRE)

→ Don’t wait for FDA approval (From Weiss Ratings) (Ad)

Should you invest $1,000 in Cadre right now?

Before you consider Cadre, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cadre wasn't on the list.

While Cadre currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AST SpaceMobile Takes Major Leap in Global Connectivity with Satellite Launch
Why Congress Is Betting Big on Broadcom in 2024
What the Bulls and Bears Are Saying About NVIDIA Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines